Deborah Smith

Deborah Smith

Wilson Sonsini Goodrich & Rosati

Contact
View Bio
RSS

Latest Posts › Patent Infringement

Share:

Duties of Disclosure and Reasonable Inquiry Before the USPTO May Include Communications with the FDA and Other Government Agencies

Spurred by President Biden's call for action to increase drug competition and a 2021 letter addressed to the U.S. Patent and Trademark Office (USPTO) by Senators Leahy and Tillis requesting the USPTO "to take action to...more

8/26/2022  /  Biden Administration , Biosimilars , Food and Drug Administration (FDA) , Intellectual Property Protection , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide